May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Correlation between Progression of Retinopathy and Metabolic Control in a Two-year Follow-up Study of Mild Nonproliferative Retinopathy in Subjects with Type 2 Diabetes
Author Affiliations & Notes
  • M.L. Ribeiro
    AIBILI, Coimbra, Portugal
  • C.L. Lobo
    Department of Ophthalmology and Centre of Ophthalmology, IBILI, University of Coimbra, Coimbra, Portugal
  • J.P. Figueira
    Department of Ophthalmology and Centre of Ophthalmology, IBILI, University of Coimbra, Coimbra, Portugal
  • M.A. Soares
    Department of Ophthalmology and Centre of Ophthalmology, IBILI, University of Coimbra, Coimbra, Portugal
  • M.G. Marques
    Department of Ophthalmology and Centre of Ophthalmology, IBILI, University of Coimbra, Coimbra, Portugal
  • R.C. Bernardes
    Department of Ophthalmology and Centre of Ophthalmology, IBILI, University of Coimbra, Coimbra, Portugal
  • J.G. Cunha-Vaz
    Department of Ophthalmology and Centre of Ophthalmology, IBILI, University of Coimbra, Coimbra, Portugal
  • Footnotes
    Commercial Relationships  M.L. Ribeiro, None; C.L. Lobo, None; J.P. Figueira, None; M.A. Soares, None; M.G. Marques, None; R.C. Bernardes, None; J.G. Cunha-Vaz, None.
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3980. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.L. Ribeiro, C.L. Lobo, J.P. Figueira, M.A. Soares, M.G. Marques, R.C. Bernardes, J.G. Cunha-Vaz; Correlation between Progression of Retinopathy and Metabolic Control in a Two-year Follow-up Study of Mild Nonproliferative Retinopathy in Subjects with Type 2 Diabetes . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3980.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Objective: A two-year prospective study of mild nonproliferative retinopathy (NPR) subjects with type 2 diabetes to evaluate progression of the retinopathy versus metabolic control. Methods: Type 2 diabetic patients with mild NPR (ETDRS gradings 14 to 47) treated with an association of three hypoglycemic agents (metformin, acarbose, and a sulphonylurea) to optimize their metabolic control were selected. 59 patients were enrolled in the study. 45 patients completed the two-year follow-up period. The eyes were examined 5 times, at six-month intervals, by stereofundus photography (seven fields), ocular fluorometry and retinal thickness analysis. Metabolic control, blood pressure and lipids were measured at each visit. Results: The number of microaneurysms, the permeability of the Blood-Aqueous Barrier (BAB) and the permeability of the Blood-Retinal Barrier (BRB) increased, respectively, by 145%, 20% and 22% at two years in eyes of patients with HgA1c values ≥ 7.5% at baseline. These increases differ significantly for the same variables in eyes of patients with HgA1c values <7.5% at baseline that showed changes of +90%, –14% and –2%, respectively. Similar increases were found comparing two groups with HgA1c ≥ 7.5% and HgA1c < 7.5% throughout the study. Conclusions: Retinopathy progression (microaneurysms, hyperpermeability of BAB and BRB) in mild NPR in subjects with type 2 diabetes is clearly correlated with HgA1c values, which are indicators of metabolic control.

Keywords: diabetic retinopathy 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×